Document is current
Any future updates will be listed below
-
Authors
Allen, Cloe
Hailemichal, Rahwa
Alkhalili, Sawsan
Martin, Sydney A.
Flood, Kelsey S.
Riley, Julia M. https://orcid.org/0000-0002-8056-2403
- License Information
-
More Information
Article History
Received: 5 March 2025
Revised: 13 February 2026
Accepted: 16 February 2026
First Online: 2 March 2026
Declarations
:
: Dr. Kelsey Flood is an investigator for Abbvie, Novartis , Incyte and Moonlake. She previously received fellowship funding from AbbVie, the National Psoriasis Foundation and Janssen Biotech, Inc, which was paid directly to her institution. Dr. Julia Riley is an investigator for Abbvie, Novartis, Incyte and Moonlake. She has served as an advisory board member for UCB. All authors report no conflicts of interest related to this work, aside from those disclosed above.
: This study, Practice patterns of Dermatology providers regarding Humira® biosimilar in the treatment of Hidradenitis Suppurativa, was reviewed by the Northwestern University Institutional Review Board and determined to be exempt from full review (STU00221707). The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and its subsequent amendments.
: Written informed consent was obtained electronically from all participants prior to survey initiation.
